KR20240041979A - 자연 살해(nk) 세포용 세포 배양 배지 - Google Patents
자연 살해(nk) 세포용 세포 배양 배지 Download PDFInfo
- Publication number
- KR20240041979A KR20240041979A KR1020247006606A KR20247006606A KR20240041979A KR 20240041979 A KR20240041979 A KR 20240041979A KR 1020247006606 A KR1020247006606 A KR 1020247006606A KR 20247006606 A KR20247006606 A KR 20247006606A KR 20240041979 A KR20240041979 A KR 20240041979A
- Authority
- KR
- South Korea
- Prior art keywords
- concentration
- cells
- acid
- medium
- plant extract
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C12N5/0646—Natural killers cells [NK], NKT cells
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70503—Immunoglobulin superfamily
- C07K14/7051—T-cell receptor (TcR)-CD3 complex
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/0018—Culture media for cell or tissue culture
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/05—Inorganic components
- C12N2500/10—Metals; Metal chelators
- C12N2500/20—Transition metals
- C12N2500/24—Iron; Fe chelators; Transferrin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/32—Amino acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/38—Vitamins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/44—Thiols, e.g. mercaptoethanol
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/70—Undefined extracts
- C12N2500/76—Undefined extracts from plants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/105—Insulin-like growth factors [IGF]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/30—Hormones
- C12N2501/33—Insulin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/50—Cell markers; Cell surface determinants
- C12N2501/599—Cell markers; Cell surface determinants with CD designations not provided for elsewhere
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Immunology (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- Microbiology (AREA)
- Hematology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicinal Chemistry (AREA)
- Toxicology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Virology (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163230189P | 2021-08-06 | 2021-08-06 | |
| US63/230,189 | 2021-08-06 | ||
| PCT/US2022/039376 WO2023014855A1 (en) | 2021-08-06 | 2022-08-04 | Cell culture medium for natural killer (nk) cells |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| KR20240041979A true KR20240041979A (ko) | 2024-04-01 |
Family
ID=83507455
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020247006606A Pending KR20240041979A (ko) | 2021-08-06 | 2022-08-04 | 자연 살해(nk) 세포용 세포 배양 배지 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20240360412A1 (https=) |
| EP (1) | EP4381049A1 (https=) |
| JP (1) | JP2024529565A (https=) |
| KR (1) | KR20240041979A (https=) |
| CN (1) | CN117916361A (https=) |
| CA (1) | CA3227822A1 (https=) |
| WO (1) | WO2023014855A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20240177181A (ko) * | 2023-06-19 | 2024-12-27 | (주)엑셀세라퓨틱스 | Nk 세포 배양용 배지 조성물 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111500535B (zh) * | 2020-04-30 | 2023-04-14 | 惠和生物技术(上海)有限公司 | 用于体外培养人自然杀伤细胞的方法和培养基 |
-
2022
- 2022-08-04 CA CA3227822A patent/CA3227822A1/en active Pending
- 2022-08-04 CN CN202280061271.0A patent/CN117916361A/zh active Pending
- 2022-08-04 JP JP2024532364A patent/JP2024529565A/ja active Pending
- 2022-08-04 KR KR1020247006606A patent/KR20240041979A/ko active Pending
- 2022-08-04 US US18/294,221 patent/US20240360412A1/en active Pending
- 2022-08-04 EP EP22782779.7A patent/EP4381049A1/en active Pending
- 2022-08-04 WO PCT/US2022/039376 patent/WO2023014855A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| JP2024529565A (ja) | 2024-08-06 |
| WO2023014855A1 (en) | 2023-02-09 |
| CA3227822A1 (en) | 2023-02-09 |
| CN117916361A (zh) | 2024-04-19 |
| US20240360412A1 (en) | 2024-10-31 |
| EP4381049A1 (en) | 2024-06-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US11578310B2 (en) | Method for producing CD4/CD8 double-positive T cells | |
| Petzer et al. | Differential cytokine effects on primitive (CD34+ CD38-) human hematopoietic cells: novel responses to Flt3-ligand and thrombopoietin. | |
| US6667034B2 (en) | Methods for regulating the specific lineages of cells produced in a human hematopoietic cell culture, methods for assaying the effect of substances on lineage-specific cell production, and cell compositions produced by these cultures | |
| KR101216201B1 (ko) | 줄기세포 및 전구세포 분화의 조절, 측정 및 이들의 용도 | |
| EP3572502B1 (en) | Method for producing cd8alpha +beta + cytotoxic t cells | |
| CN115261318B (zh) | 产生自然杀伤细胞的方法 | |
| JP7747352B2 (ja) | 操作されたガンマデルタt細胞ならびにその作製方法および使用方法 | |
| CN107922925A (zh) | 用于自然杀伤细胞扩增的方法 | |
| RU2007132733A (ru) | Стромальные клетки, выделенные из жировой ткани взрослого организма, проявляющие свойства эндотелиальных клеток | |
| EP3892722A1 (en) | Production method for t cells or nk cells, medium for culturing t cells or nk cells, method for culturing t cells or nk cells, method for maintaining undifferentiated state of undifferentiated t cells, and growth-accelerating agent for t cells or nk cells | |
| WO2020027094A1 (ja) | iPS細胞を介して再生T細胞集団を製造する方法 | |
| CN115558641A (zh) | 高纯度效应免疫细胞群及其培养方法、试剂组合物和应用 | |
| WO2019070021A1 (ja) | iPS細胞由来の遺伝的多様性を有するT細胞集団の製造方法 | |
| KR20240041979A (ko) | 자연 살해(nk) 세포용 세포 배양 배지 | |
| Lee et al. | Promotion of stem cell proliferation by vegetable peptone | |
| Juhl et al. | Adipose Tissue‐Derived Stromal Cells Induce a Highly Trophic Environment While Reducing Maturation of Monocyte‐Derived Dendritic Cells | |
| HK40103422A (zh) | 天然杀伤(nk)细胞的细胞培养基 | |
| US20220233665A1 (en) | Medicinal composition | |
| EP4130253A1 (en) | T cell progenitor production method | |
| JPWO2005056778A1 (ja) | 造血幹細胞の分化抑制又は増殖方法 | |
| AU2021416169B2 (en) | Engineered gamma delta t cells and methods of making and using thereof | |
| WO2023243627A1 (ja) | 胸腺上皮細胞の製造方法 | |
| CN121427820A (zh) | 一种γδT细胞的培养基及培养方法 | |
| ITTO20060365A1 (it) | Uso di sostanze parasimpaticolitiche per potenziare ed accelerare il differenziamento di cellule staminali, relativo procedimento e relativi prodotti | |
| Amedeo et al. | Identification and Quantification of Secreted Proteins Driving Hematopoiesis in an Induced Pluripotent Stem Cell Coculture System |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PA0105 | International application |
St.27 status event code: A-0-1-A10-A15-nap-PA0105 |
|
| PG1501 | Laying open of application |
St.27 status event code: A-1-1-Q10-Q12-nap-PG1501 |
|
| E13 | Pre-grant limitation requested |
Free format text: ST27 STATUS EVENT CODE: A-2-3-E10-E13-LIM-X000 (AS PROVIDED BY THE NATIONAL OFFICE) |
|
| E13-X000 | Pre-grant limitation requested |
St.27 status event code: A-2-3-E10-E13-lim-X000 |
|
| P11 | Amendment of application requested |
Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P11-NAP-X000 (AS PROVIDED BY THE NATIONAL OFFICE) |
|
| P11-X000 | Amendment of application requested |
St.27 status event code: A-2-2-P10-P11-nap-X000 |
|
| P11 | Amendment of application requested |
Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P11-NAP-X000 (AS PROVIDED BY THE NATIONAL OFFICE) |
|
| P11-X000 | Amendment of application requested |
St.27 status event code: A-2-2-P10-P11-nap-X000 |
|
| D18 | Deferred examination requested |
Free format text: ST27 STATUS EVENT CODE: A-1-2-D10-D18-EXM-X000 (AS PROVIDED BY THE NATIONAL OFFICE) |
|
| D18-X000 | Deferred examination requested |
St.27 status event code: A-1-2-D10-D18-exm-X000 |